Is launching a value brand the most effective strategy for your product? A guide for making a “go-no-go” value brand launch decision by thoughtful consideration at each step of the process. More ►
Recent Developments in Global Pricing & Market Access
An analysis of country-level pricing and reimbursement trends resulting from changing policy and political climates.More ►
CMED: The "Curupira" of Brazil's Pharma Market
Gain insight into CMED’s elusive decision-making process through a retrospective study evaluating clinical and economic criteria and list prices at launch for a selection of innovative drugs in Brazil.More ►
German AMNOG Price negotiation black box: Which factors contribute the most to achieve a price premium over the comparator?
There is a lot at stake when it comes to achieving the deserved price for innovative pharmaceuticals in Germany in the post-AMNOG market. Understanding the level of impact of different factors on the achievable price is crucial when developing a launch strategy in Germany.More ►